scispace - formally typeset
S

Serge Resnikoff

Researcher at University of New South Wales

Publications -  201
Citations -  82499

Serge Resnikoff is an academic researcher from University of New South Wales. The author has contributed to research in topics: Population & Visual impairment. The author has an hindex of 60, co-authored 187 publications receiving 56400 citations. Previous affiliations of Serge Resnikoff include Case Western Reserve University & Guy's and St Thomas' NHS Foundation Trust.

Papers
More filters
Journal Article

Global Magnitude of Visual Impairment Caused by Uncorrected Refractive Errors in 2004/prevalence Mondiale Des Deficiences Visuelles Dues a Des Defauts De Refraction Non Corriges En 2004/magnitud Mundial De Las Discapacidades Visuales Por Defectos De Refraccion No Corregidos En 2004

TL;DR: In this article, the authors presented the estimate of the prevalence of visual impairment from uncorrected refractive errors for all ages over 5 years at regional and global levels, based on recent published and unpublished surveys.
Journal ArticleDOI

Global trends in blindness and vision impairment due to corneal opacity 1984-2020: a meta-analysis.

TL;DR: In this paper , the authors provide global estimates of the prevalence of corneal blindness and vision impairment in adults 40 years of age and older and examine the burden by age, sex, and geographic region from 1984 through 2020.
Journal ArticleDOI

Improving population‐level refractive error monitoring via mixture distributions

TL;DR: This paper investigated the ability of mixture models to describe refractive error distributions and found that mixture models can be used to sample and describe the distribution of refractive errors in populations, which is critical to understanding eye care needs, refractive differences between groups and factors affecting refractive development.
Journal ArticleDOI

Editorial: International Myopia Institute White Paper Series 2023

TL;DR: The first series of International Myopia Institute (IMI) white papers was published early in 2019 in response to the growing need for consensus and clinical management guidance on the ever growing, and sometimes conflicting, evidence base around myopia development and management as mentioned in this paper .